Related-Party Transactions - Additional Information (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Mar. 30, 2020 |
Dec. 31, 2019 |
Mar. 31, 2020 |
|
| Related Party Transaction [Line Items] | |||
| Receivable from agreement | $ 6,298,000 | $ 9,079,000 | |
| Merck | Sutro Biopharma | |||
| Related Party Transaction [Line Items] | |||
| Equity interest percentage | 11.80% | 11.70% | |
| SutroVax | |||
| Related Party Transaction [Line Items] | |||
| Receivable from agreement | $ 14,000 | $ 49,000 | |
| Percentage common stock ownership interest | 4.10% | 5.60% | |
| Carrying value of common stock under the cost method | $ 0 | $ 0 |
| X | ||||||||||
- Definition Carrying value of common stock. No definition available.
|
| X | ||||||||||
- Definition Common stock ownership percentage. No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|